Newsletter | August 26, 2026

08.26.26 -- This WhichTrial Report Breaks Down The U.S. Clinical Trial Recruiting Pipeline

SPONSOR

Clinical Innovations in AI: A Technology Showcase

Join us on September 10, 2026, at 10:00 AM ET for Clinical Innovations in AI, a virtual technology showcase exploring how AI is transforming clinical research. Leading innovators will demonstrate real-world solutions that help pharmaceutical and biotech sponsors streamline operations, improve decision-making, reduce trial burdens, and accelerate study execution. Discover emerging technologies, practical use cases, and opportunities to drive greater impact across the clinical trial lifecycle.

DECENTRALIZED TRIALS

Ask An Expert Before Shredding Your Mobile Device CAPEX

Tasked with buying your company's mobile devices and not sure where to start? Discover the questions you should ask and the information you need to know before consulting an expert.

Finding The Solution(s) That Meet Patient, Site, And Sponsor Needs

Poor enrollment and retention often stem from patient burden and limited site access. Learn how leveraging diverse site networks and remote support can transform the clinical trial experience.

TRIAL MANAGEMENT

The U.S. Clinical Trial Recruiting Pipeline Report – June 2026

This WhichTrial report breaks down which drug trials are growing the most and the least, drugs that are no longer being studied, and new drugs from May 1 to June 30, 2026.

Big Futures For Emerging Biopharma: Navigating Biotech Hurdles

Emerging biopharma drives agile, data-driven, patient-focused drug development. Discover how to overcome complexity, speed timelines, and thrive in a fast-changing healthcare landscape.

The Protocol Amendment Trap (And How Sponsors Free)

Clinical trial complexity is rising, with 76% of Phase I-IV trials now requiring protocol amendment. The reality is that one-in-four amendments are avoidable through more rigorous initial planning.

Capital Efficiency In Cardiovascular Outcomes Trials

New modeling shows aligning clinical and manufacturing operations in heart trials can cut costs, speed timelines, and boost expected program value.

Advances In Metabolic Research: Beyond GLP-1

GLP-1 therapies are expanding fast, from T2D into obesity, MASH, and neurology. Learn how next-gen multi-agonist incretins, a case study, and market forecasts for patients can shape your strategy.

Streamline Pediatric Clinical Trials And Reduce Documentation Errors

Utilizing a centralized, automated platform can eliminate the friction of manual accountability logs, ensuring audit readiness while providing real-time visibility into financial reporting.

The Challenge: Complexity In Modern Clinical Trials

Modern trials face rising protocol, operational, and patient complexity. Learn what's driving it and what teams need in order to manage it with confidence.

Connect With Clinical Leader: